Literature DB >> 2126268

Labile type-specific antigen of Moraxella catarrhalis.

S J Norkus1, J W Vennes.   

Abstract

By using hot acid extract and double-diffusion studies, an antigen isolated from clinical strains of Moraxella catarrhalis, designated the C antigen, was studied. The antigen is labile, relatively trypsin insensitive, and either polysaccharide or glycoconjugate in nature. At least two serologically distinct C antigens have been identified.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2126268      PMCID： PMC268283          DOI： 10.1128/jcm.28.12.2815-2817.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen?

Authors:  M A Johnson; W L Drew; M Roberts
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

2.  Serological identification of Branhamella catarrhalis. Serological evidence for infection.

Authors:  I Eliasson
Journal:  Drugs       Date:  1986       Impact factor: 9.546

3.  Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association.

Authors:  L A Diamond; B Lorber
Journal:  Am Rev Respir Dis       Date:  1984-05

Review 4.  Infection and Branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; M A Calder
Journal:  Biomed Pharmacother       Date:  1985       Impact factor: 6.529

5.  Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.

Authors:  G V Doern; S A Morse
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

6.  Development of bactericidal antibody during Branhamella catarrhalis infection.

Authors:  A J Chapman; D M Musher; S Jonsson; J E Clarridge; R J Wallace
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

7.  Direct and indirect pathogenicity of Branhamella catarrhalis.

Authors:  I Brook
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  A protein antigen characteristic of Branhamella catarrhalis. Serological identification of the genus.

Authors:  I Eliasson
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-10

9.  A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis.

Authors:  T F Patterson; J E Patterson; B L Masecar; G E Barden; W J Hierholzer; M J Zervos
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

10.  Branhamella catarrhalis as a cause of bacteremic pneumonia.

Authors:  M Malkamäki; E Honkanen; M Leinonen; P H Mäkelä
Journal:  Scand J Infect Dis       Date:  1983
View more
  3 in total

1.  Serological cross-reactions between Moraxella (Branhamella) catarrhalis and other oropharyngeal bacteria.

Authors:  I Jönsson; T Holme; A Krook; M Thorén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

2.  Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

Authors:  M E Helminen; R Beach; I Maciver; G Jarosik; E J Hansen; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 3.  The clinical relevance of necroinflammation-highlighting the importance of acute kidney injury and the adrenal glands.

Authors:  Wulf Tonnus; Florian Gembardt; Markus Latk; Simon Parmentier; Christian Hugo; Stefan R Bornstein; Andreas Linkermann
Journal:  Cell Death Differ       Date:  2018-09-17       Impact factor: 15.828
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.